Trial endpoints for drug approval in oncology : ChemopreventionBEITZ, Julie.Urology (Ridgewood, NJ). 2001, Vol 57, Num 4A, pp 213-215, issn 0090-4295Article

Spontaneous reports of thrombocytopenia in association with quinine: Clinical attributes and timing related to regulatory actionBRINKER, Allen D; BEITZ, Julie.American journal of hematology. 2002, Vol 70, Num 4, pp 313-317, issn 0361-8609Article

Use of a spontaneous adverse drug events database for identification of unanticipated drug benefitsBRINKER, Allen; BEITZ, Julie.Clinical pharmacology and therapeutics. 2002, Vol 71, Num 1, pp 99-102, issn 0009-9236Article

An analysis of reports of depression and suicide in patients treated with isotretinoinWYSOWSKI, Diane K; PITTS, Marilyn; BEITZ, Julie et al.Journal of the American Academy of Dermatology. 2001, Vol 45, Num 4, pp 515-519, issn 0190-9622Article

Aseptic meningitis associated with rofecoxibBONNEL, Renan A; VILLALBA, Maria L; KARWOSKI, Claudia B et al.Archives of internal medicine (1960). 2002, Vol 162, Num 6, pp 713-715, issn 0003-9926Article

Renal failure associated with the use of celecoxib and rofecoxibAHMAD, Syed R; KORTEPETER, Cindy; BRINKER, Allen et al.Drug safety. 2002, Vol 25, Num 7, pp 537-544, issn 0114-5916Article

The US Food and Drug Administration's registry of patients with pergolide-associated valvular heart diseaseFLOWERS, Charlene M; RACOOSIN, Judith A; LU, Susan L et al.Mayo Clinic proceedings. 2003, Vol 78, Num 6, pp 730-731, issn 0025-6196, 2 p.Article

Allergic contact dermatitis from topical doxepin: Food and Drug Administration's postmarketing surveillance experienceBONNEL, Renan A; LA GRENADE, Lois; KARWOSKI, Claudia B et al.Journal of the American Academy of Dermatology. 2003, Vol 48, Num 2, pp 294-295, issn 0190-9622, 2 p.Article